Evidence map›Paper›PMID 31893233›Full record

ArticleTomography (Ann Arbor, Mich.)2019

Short-Term Environmental Conditioning Enhances Tumorigenic Potential of Triple-Negative Breast Cancer Cells.

Samantha S Eckley, Johanna M Buschhaus, Brock A Humphries, Tanner H Robison, Kathryn E Luker, Gary D Luker

Open access · goldAbstract read
In one paragraph

Article in Tomography (Ann Arbor, Mich.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Cancer spreading patterns based on epithelial-mesenchymal plasticity.Frontiers in cell and developmental biology · 2024
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Samantha S EckleyUnit for Laboratory Animal Medicine, University of Michigan Medical School, Ann Arbor, MI.
Johanna M BuschhausDepartment of Biomedical Engineering, University of Michigan College of Engineering and Medical School, Ann Arbor, MI.
Brock A HumphriesDepartment of Radiology Center for Molecular Imaging, University of Michigan Medical School, Ann Arbor, MI; and.
Tanner H RobisonDepartment of Biomedical Engineering, University of Michigan College of Engineering and Medical School, Ann Arbor, MI.
Kathryn E LukerDepartment of Biomedical Engineering, University of Michigan College of Engineering and Medical School, Ann Arbor, MI.
Gary D LukerDepartment of Biomedical Engineering, University of Michigan College of Engineering and Medical School, Ann Arbor, MI.
University of Michigan–Ann Arbor · US

Funding

Interstitial Fluid Flow Regulates Glioma Cell InvasionR37CA222563 · NCI · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI MUNSON, JENNIFER M · 2018 to 2024
$4.0M
Environmental Regulation of Cancer Stem Cell Plasticity in MetastasisU01CA210152 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LAHANN, JOERG, LUKER, GARY D · 2017 to 2021
$3.6M
Imaging Disease Heterogeneity and Response to Therapy in MyelofibrosisR01CA238023 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LUKER, GARY D, ROSS, BRIAN D. · 2019 to 2023
$3.1M
Integrators of Metastatic PotentialR01CA238042 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GHOSH, PRADIPTA, LUKER, GARY D · 2019 to 2023
$2.3M
Systems Bioengineering of Cancer Cell MigrationR01CA196018 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LINDERMAN, JENNIFER JEAN, LUKER, GARY D · 2015 to 2019
$2.2M
Specialist in Multi-Scale Molecular Imaging of Tumor EnvironmentsR50CA221807 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Kathryn Luker · 2018 to 2026
$1.6M
A High Throughput Human Tumor Modeling Technology for Cancer Drug DiscoveryR33CA225549 · NCI · UNIVERSITY OF AKRON · PI LUKER, GARY D, TAVANA, HOSSEIN · 2019 to 2021
$1.4M
NCI NIH HHS R01 CA196018NCI NIH HHS R01 CA238023NCI NIH HHS R01 CA238042NCI NIH HHS R33 CA225549NCI NIH HHS R37 CA222563NCI NIH HHS R50 CA221807NCI NIH HHS U01 CA210152
6 · The paper itself

Abstract

Tumor microenvironments expose cancer cells to heterogeneous, dynamic environments by shifting availability of nutrients, growth factors, and metabolites. Cells integrate various inputs to generate cellular memory that determines trajectories of subsequent phenotypes. Here we report that short-term exposure of triple-negative breast cancer cells to growth factors or targeted inhibitors regulates subsequent tumor initiation. Using breast cancer cells with different driver mutations, we conditioned cells lines with various stimuli for 4 hours before implanting these cells as tumor xenografts and quantifying tumor progression by means of bioluminescence imaging. In the orthotopic model, conditioning a low number of cancer cells with fetal bovine serum led to enhancement of tumor-initiating potential, tumor volume, and liver metastases. Epidermal growth factor and the mTORC1 inhibitor ridaforolimus produced similar but relatively reduced effects on tumorigenic potential. These data show that a short-term stimulus increases tumorigenic phenotypes based on cellular memory. Conditioning regimens failed to alter proliferation or adhesion of cancer cells in vitro or kinase signaling through Akt and ERK measured by multiphoton microscopy in vivo, suggesting that other mechanisms enhanced tumorigenesis. Given the dynamic nature of the tumor environment and time-varying concentrations of small-molecule drugs, this work highlights how variable conditions in tumor environments shape tumor formation, metastasis, and response to therapy.

Indexed as

CarcinogenesisTumor MicroenvironmentAnimalsCell AdhesionCell CountCell Line, TumorCell ProliferationDisease Models, AnimalDisease ProgressionEpidermal Growth FactorExtracellular Signal-Regulated MAP KinasesFemaleHumansLuminescent MeasurementsMechanistic Target of Rapamycin Complex 1Neoplasm MetastasisEpidermal Growth FactorExtracellular Signal-Regulated MAP KinasesMechanistic Target of Rapamycin Complex 1Proto-Oncogene Proteins c-aktridaforolimusSerum Albumin, BovineSirolimusbioluminescencebreast cancerFluorescencesignaling

Identifiers

PMID31893233
PMCPMC6935992
OpenAlexW3000509636

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.